In fact, according to IQVIA, 52% of the wholesale acquisition cost, which is considered one of the best approximations of the ...

In a discussion on global trade disruption, Thani Jambulingam, PhD, professor of food, pharma, and healthcare business at ...

CEVA Logistics' acquisition of Fagioli Group enhances its end-to-end logistics capabilities, integrating Fagioli's expertise ...

In today’s Pharma Pulse, House Republicans block a critical insurance subsidy extension, as new research highlights the oncology benefits of GLP-1s.

In today’s Pharma Pulse, Novartis and Moderna anchor a domestic manufacturing surge, while AI-driven biomarker discovery and ...

Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to ...

Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory ...

In today’s Pharma Pulse, SOBI strengthens its gout franchise by acquiring Arthrosi Therapeutics for up to $1.5 billion, ...

The evolution from time-consuming manual reviews to automated detection and now to intelligent action is reimagining the ...

Major regulatory developments—including the Medicare MFP program, the introduction of the 340B rebate, changes to the MDRP, and updates to the physician fee schedule—are reshaping commercial ...

In mid-November, to boost domestic drug product manufacturing of its own, Moderna announced 3 a new $140 million investment ...

At a time when investors are questioning the sustainability of pharmaceutical business models, reliable execution has become ...